<--- Back to Details
First PageDocument Content
Anticoagulants / Coagulation system / Heparins / Morpholines / Rivaroxaban / Thiophenes / Deep vein thrombosis / Enoxaparin sodium / Venous thrombosis / Hematology / Blood / Medicine
Anticoagulants
Coagulation system
Heparins
Morpholines
Rivaroxaban
Thiophenes
Deep vein thrombosis
Enoxaparin sodium
Venous thrombosis
Hematology
Blood
Medicine

Add to Reading List

Source URL: circ.ahajournals.org

Download Document from Source Website

Share Document on Facebook

Similar Documents

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1r9dZ - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

RECOTHROM, Thrombin topical (Recombinant) Package Insert

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document